Skip to main navigation Skip to search Skip to main content

A Phase 2 Global Multicenter Long-term Safety Study Designed to Assess the Safety & Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy

Project: Research

Project Details

StatusActive
Effective start/end date12/19/2403/16/27

Funding

  • Biohaven Pharmaceuticals Holding Company Ltd.: $23,000.00